Skip to content
Stop using now Drug recall · FDA · Published April 8, 2021

Ginseng Power 5000 Capsules: Undeclared Sildenafil/Tadalafil Risk

NSNY Distributor Inc recalls Ginseng Power 5000 capsules due to undeclared sildenafil and tadalafil. These substances are not approved for use in dietary supplements.

🇺🇸 FDA recall #D-0642-2021DrugGS Natural Co ›
Take action

Contact the company

Recalling firmNSNY Distributor Inc4570 192nd St · Flushing, NY 11358-3438
✎ GovInfoNow plain-language explainer

What happened, in plain English

NSNY Distributor Inc has recalled all Ginseng Power 5000 capsules because they contain undeclared sildenafil and tadalafil without proper FDA approval. This poses a risk of serious health effects due to the unapproved medications. Read more at govinfonow.com/recall/36216-ginseng-power-5000-capsules-undeclared-sildenafil-tadalafil-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36216-ginseng-power-5000-capsules-undeclared-sildenafil-tadalafil-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0642-2021

Cite this page

“Ginseng Power 5000 Capsules: Undeclared Sildenafil/Tadalafil Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36216-ginseng-power-5000-capsules-undeclared-sildenafil-tadalafil-risk. Based on FDA recall #D-0642-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0642-2021%22&limit=1).

Why it’s dangerous

The capsules contain undeclared sildenafil and tadalafil, which are prescription medications not approved for use in dietary supplements. These substances can cause serious health effects if taken without proper medical supervision.

Who’s affected

Anyone who purchased the Ginseng Power 5000 capsules from GS Natural Co in Los Angeles, CA. People using these capsules for health reasons may be at risk of serious side effects.

How to tell if you have this one

Check for the product name 'Ginseng Power 5000 capsules' with 1 count per blister card. The manufacturer is GS Natural Co from Los Angeles, CA. All lots are affected.

  • Brand
    GS Natural Co
  • Product
    Ginseng Power 5000 capsule, 1- count per blister card, GS Natural Co, Los Angeles, CA 90010, UPC 0 40232 18144 3
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Ongoing
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsQuantity
D-0641-2021Premium OrgaZEN 7000 capsule, 1-count per blister card, distributed by: Nutra Vita Co, Santa Fe Springs, CA, Made in USA , UPC 0 40232 32555 7; all lots2600 capsules
D-0642-2021Ginseng Power 5000 capsule, 1- count per blister card, GS Natural Co, Los Angeles, CA 90010, UPC 0 40232 18144 3; all lots399 capsules
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Ginseng Power 5000 capsules as they contain undeclared prescription medications.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Apr 8, 202112. FDA classified it Class I: Jun 28, 202123. Published in FDA’s Enforcement Report: Jul 7, 202132021
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0642-2021 (April 8, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0642-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA